Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Terminated
1(25%)

Phase Distribution

Ph phase_2
1
25%
Ph phase_4
1
25%
Ph phase_3
2
50%

Phase Distribution

0

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
2(50.0%)
Phase 4Post-market surveillance
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (25.0%)
Phase 32 (50.0%)
Phase 41 (25.0%)

Trials by Status

completed375%
terminated125%

Recent Activity

0 active trials
Showing 4 of 4
terminatedphase_2

Pharmacologic Modulation of Hippocampal Activity in Psychosis

NCT04277936
completedphase_3

Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy

NCT00150748
completedphase_3

A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures

NCT00280696
completedphase_4

Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients

NCT01491113

Clinical Trials (4)

Showing 4 of 4 trials
NCT04277936Phase 2

Pharmacologic Modulation of Hippocampal Activity in Psychosis

Terminated
NCT00150748Phase 3

Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy

Completed
NCT00280696Phase 3

A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures

Completed
NCT01491113Phase 4

Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4